Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gretchen M Unger

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Laryngoscope|March 4, 2005
Improving surgical wound healing with basic fibroblast growth factor after radiationDavid B Hom, Gretchen M Unger, Kerri J Pernell, et al.
Molecular Cancer Research : MCR|January 7, 2005
Induction of apoptosis by antisense CK2 in human prostate cancer xenograft modelJoel W Slaton, Gretchen M Unger, Daniel T Sloper, et al.
Breast Cancer Research : BCR|April 4, 2015
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapyBetsy T Kren, Gretchen M Unger, Md J Abedin, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2017
CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of CancerJaneen H Trembley, Betsy T Kren, Md Joynal Abedin, et al.
Human Gene Therapy. Clinical Development|March 25, 2017
Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck CancerClaire M Cannon, Janeen H Trembley, Betsy T Kren, et al.
Cancer Letters|November 5, 2011
Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cellsJaneen H Trembley, Gretchen M Unger, Vicci L Korman, et al.
American Journal of Veterinary Research|July 25, 2017
Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of catsClaire M Cannon, Janeen H Trembley, Betsy T Kren, et al.
Molecular Cancer Therapeutics|May 29, 2014
Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinomaGretchen M Unger, Betsy T Kren, Vicci L Korman, et al.
The Journal of Clinical Investigation|June 11, 2009
Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A miceBetsy T Kren, Gretchen M Unger, Lucas Sjeklocha, et al.
Molecular and Cellular Pharmacology|April 21, 2015
Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell ProliferationJaneen H Trembley, Gretchen M Unger, Omar Cespedes Gomez, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Laryngoscope|March 4, 2005
Improving surgical wound healing with basic fibroblast growth factor after radiationDavid B Hom, Gretchen M Unger, Kerri J Pernell, et al.
Molecular Cancer Research : MCR|January 7, 2005
Induction of apoptosis by antisense CK2 in human prostate cancer xenograft modelJoel W Slaton, Gretchen M Unger, Daniel T Sloper, et al.
Breast Cancer Research : BCR|April 4, 2015
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapyBetsy T Kren, Gretchen M Unger, Md J Abedin, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2017
CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of CancerJaneen H Trembley, Betsy T Kren, Md Joynal Abedin, et al.
Human Gene Therapy. Clinical Development|March 25, 2017
Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck CancerClaire M Cannon, Janeen H Trembley, Betsy T Kren, et al.
Cancer Letters|November 5, 2011
Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cellsJaneen H Trembley, Gretchen M Unger, Vicci L Korman, et al.
American Journal of Veterinary Research|July 25, 2017
Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of catsClaire M Cannon, Janeen H Trembley, Betsy T Kren, et al.
Molecular Cancer Therapeutics|May 29, 2014
Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinomaGretchen M Unger, Betsy T Kren, Vicci L Korman, et al.
The Journal of Clinical Investigation|June 11, 2009
Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A miceBetsy T Kren, Gretchen M Unger, Lucas Sjeklocha, et al.
Molecular and Cellular Pharmacology|April 21, 2015
Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell ProliferationJaneen H Trembley, Gretchen M Unger, Omar Cespedes Gomez, et al.
Pageof 2